Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Personalis, Inc. - Common Stock (NQ:PSNL)

9.450 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Personalis, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
What Analysts Are Saying About Personalis Stock
 
Via Benzinga
Personalis Reports Third Quarter 2024 Financial Results
From Personalis, Inc.
Via Business Wire
Personalis to Present at the Stifel 2024 Healthcare Conference
From Personalis, Inc.
Via Business Wire
Personalis to Announce Third Quarter 2024 Financial Results
From Personalis, Inc.
Via Business Wire
ESMO 2024 Data Expands on Compelling Performance of Personalis NeXT Personal® MRD Test
From Personalis, Inc.
Via Business Wire
Assessing Personalis: Insights From 4 Financial Analysts
 
Via Benzinga
Biotech Stock Soars 60% in 2024: Cathie Wood’s Bold Investment
Tempus AI is a hot healthcare stock that investors should be aware of. It is using AI to pursue "precision medicine", especially in cancer research. 
Via MarketBeat
Topics Artificial Intelligence ETFs
Personalis to Participate at Upcoming Investor Conferences
From Personalis, Inc.
Via Business Wire
Why Tempus AI Stock Skyrocketed Nearly 22% Today
It deepened its involvement in a client and peer. 
Via The Motley Fool
Topics Artificial Intelligence
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Personalis, Inc.
Via Business Wire
Breaking Down Personalis: 4 Analysts Share Their Views
 
Via Benzinga
4 Analysts Have This To Say About Personalis
 
Via Benzinga
Personalis and Tempus Announce Expanded Collaboration
From Personalis, Inc.
Via Business Wire
PSNL Stock Earnings: Personalis Beats EPS, Beats Revenue for Q2 2024
PSNL stock results show that Personalis beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Personalis Reports Second Quarter 2024 Financial Results
From Personalis, Inc.
Via Business Wire
Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%
From Myriad Genetics, Inc.
Via GlobeNewswire
Personalis to Participate at the 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
From Personalis, Inc.
Via Business Wire
Personalis to Announce Second Quarter 2024 Financial Results
From Personalis, Inc.
Via Business Wire
Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to Testing
From Myriad Genetics, Inc.
Via GlobeNewswire
Personalis to Participate at the TD Cowen 3rd Annual Tools / Dx Revolution Conference
From Personalis, Inc.
Via Business Wire
Personalis Provides Dial-in and Updated Date for ASCO Highlights Conference Call
From Personalis, Inc.
Via Business Wire
ASCO Data Highlights NeXT Personal® Ultra-sensitive MRD Performance in Early-stage Breast Cancer Recurrence Detection and Immunotherapy Monitoring
From Personalis, Inc.
Via Business Wire
Personalis Announces Start of Cancer MRD Testing Commercialization Collaboration with Tempus
From Personalis, Inc.
Via Business Wire
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
 
Via Benzinga
Personalis Announces Podium Presentations and Abstracts Accepted at ASCO 2024
From Personalis, Inc.
Via Business Wire
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Personalis, Inc.
Via Business Wire
PSNL Stock Earnings: Personalis Beats EPS, Beats Revenue for Q1 2024
PSNL stock results show that Personalis beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Personalis Reports First Quarter 2024 Financial Results
From Personalis, Inc.
Via Business Wire
Personalis to Announce First Quarter 2024 Financial Results
From Personalis, Inc.
Via Business Wire
Cathie Wood's Ark Laps Up $3.3M Worth Of Tesla As Stock Falls For 3rd Straight Session, Sheds Shares Of This Sports Betting Company
Tesla found favor with bullish fund manager Cathie Wood, as her firm lapped up Tesla shares following its 10% slide over three sessions. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.